| 5-R01-EB031935-03 |
A high-performance and versatile technology for precision microbiome engineering |
Harris Wang |
Columbia University Health Sciences |
| 5-R21-EB033595-02 |
A Molecular Grammar for Guide RNAs (gRNAs) with Engineered Secondary Structures |
Eric Josephs |
University of North Carolina Greensboro |
| 1-DP2-EB035891-01 |
A Novel Class of Synthetic Receptors to Empower the Age of mRNA Therapies |
Xiaojing Gao |
Stanford University |
| 1-R21-EB033459-01A1 |
A Novel Vector Platform to Actualize T Cell Modification In Vivo |
David Curiel |
Washington University |
| 5-R01-EB027895-04 |
Accelerating phage evolution and tools via synthetic biology and machine learning |
Sam Nugen |
Cornell University |
| 5-R21-EB032491-03 |
An Engineered CRISPR System for Boosting Tumor Immunogenicity. |
Weixin Tang |
University of Chicago |
| 5-R21-EB028385-03 |
Anti-catabolic drug anchored cationic exosomes for cartilage targeting and repair |
Ambika Bajpayee |
Northeastern University |
| 5-R21-EB033858-02 |
Cancer Classifiers Based on RNA Sensors in Living Cells |
Xiaojing Gao |
Stanford University |
| 5-R01-EB030015-04 |
Cell targeting with synthetic sense-and-respond protease circuits |
Michael Elowitz |
California Institute of Technology |
| 5-R01-EB031124-04 |
Directed evolution of a sequence-specific targeting technology for therapeutic gene delivery to the human genome. |
Jesse Owens |
University of Hawaii at Manoa |
